Plasma C-peptide and serum insulin antibodies in diabetic patients receiving pancreatic transplants. 1980

J Ostman, and P Arner, and C G Groth, and R Gunnarsson, and L Heding, and G Lundgren

Plasma C-peptide and serum insulin antibody levels were determined in 5 diabetic patients undergoing vascularized pancreatic transplantation. The grafts functioned well at first and exogenous insulin could be withdrawn, but one to 7 weeks later the grafts were rejected. After the transplantation there was an increase in the fasting plasma C-peptide level, and B-cell stimulation with glucose or glucagon evoked a C-peptide response. Healing of ischaemic damage was reflected in an increase in the C-peptide level. During graft rejection the C-peptide level fell. Measurement of plasma C-peptide levels provides a direct index of the B-cell function of the pancreatic graft. After transplantation the insulin antibody level fell exponentially, with an apparent half life of 10-11 days, whereas the level of total IgG was variable. The results indicate that formation of insulin antibodies ceases immediately on removal of the immunogenic stimulus, that is, on withdrawal of xenogeneic insulin.

UI MeSH Term Description Entries
D007330 Insulin Antibodies Antibodies specific to INSULIN. Antibodies, Insulin
D008297 Male Males
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic

Related Publications

J Ostman, and P Arner, and C G Groth, and R Gunnarsson, and L Heding, and G Lundgren
July 1992, Diabetes care,
J Ostman, and P Arner, and C G Groth, and R Gunnarsson, and L Heding, and G Lundgren
August 1979, Diabetes,
J Ostman, and P Arner, and C G Groth, and R Gunnarsson, and L Heding, and G Lundgren
September 1987, Metabolism: clinical and experimental,
J Ostman, and P Arner, and C G Groth, and R Gunnarsson, and L Heding, and G Lundgren
October 1991, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
J Ostman, and P Arner, and C G Groth, and R Gunnarsson, and L Heding, and G Lundgren
January 1986, Diabetes care,
J Ostman, and P Arner, and C G Groth, and R Gunnarsson, and L Heding, and G Lundgren
January 1980, Journal of endocrinological investigation,
J Ostman, and P Arner, and C G Groth, and R Gunnarsson, and L Heding, and G Lundgren
January 1983, Lancet (London, England),
J Ostman, and P Arner, and C G Groth, and R Gunnarsson, and L Heding, and G Lundgren
November 1984, Diabetic medicine : a journal of the British Diabetic Association,
J Ostman, and P Arner, and C G Groth, and R Gunnarsson, and L Heding, and G Lundgren
July 1987, The Korean journal of internal medicine,
J Ostman, and P Arner, and C G Groth, and R Gunnarsson, and L Heding, and G Lundgren
January 1988, Acta medica Scandinavica,
Copied contents to your clipboard!